Product Information

MELOXICAM 15 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0186 per EA under NDC 69097015915. Its NADAC has been published 604 times since Jan 28, 2015.

FDA first approved this application on Jul 19, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MELOXICAM 15 MG TABLET

meloxicam
$0.0186per EA

Strength

15 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097015915

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

MELOXICAM

Approval Type

Generic (ANDA)

FDA Application

ANDA077929

FDA Approved

7/19/2006

TE Code

AB

On Market Since

7/19/2006

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for MELOXICAM 15 MG TABLET has been published 604 times since Jan 28, 2015, and over the history we have for it it has declined 29.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0186 per EA
All-time high$0.0285 (Jun 10, 2015)
All-time low$0.0173 (Nov 20, 2024)
52-week high$0.0202
52-week low$0.0186
Median price$0.0214
Average price$0.0217
Largest weekly change-17.1% (Nov 20, 2024)
Weeks tracked604
Tracking sinceJan 28, 2015

Price History

1W

+0.1%

1M

+0.1%

3M

-2.2%

6M

-5.4%

1Y

-7.6%

3Y

-15.9%

5Y

-15.3%

All

-29.4%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MELOXICAM 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MELOXICAM 15 MG TABLET, manufactured by Cipla USA Inc., is $0.0186 per EA (NDC 69097015915), effective Aug 19, 2026.

How has the price of MELOXICAM 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for MELOXICAM 15 MG TABLET has declined 29.4%. It has been tracked across 604 weekly CMS publications since Jan 28, 2015.

What are the highest and lowest recorded NADAC prices for MELOXICAM 15 MG TABLET?

Since Jan 28, 2015, the NADAC for MELOXICAM 15 MG TABLET has ranged from a low of $0.0173 (Nov 20, 2024) to a high of $0.0285 (Jun 10, 2015), with a median of $0.0214 per EA.

Are there cheaper alternatives to MELOXICAM 15 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MELOXICAM 15 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MELOXICAM 15 MG TABLET?

MELOXICAM 15 MG TABLET (NDC 69097015915) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.